IOL Chemicals & Pharmaceuticals Ltd.

NSE: IOLCP  SECTOR: Pharmaceuticals & Drugs

780.65
+37.35 (5.02%)

Price Summary

Today's High

₹ 785

Today's Low

₹ 740.1

52 Week High

₹ 898.4

52 Week Low

₹ 147.35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

4582.84501363 Cr.

Enterprise Value

4484.18501363 Cr.

No. of Shares

5.8705502 Cr.

P/E

10.35

P/B

4.19

Face Value

₹ 10

Div. Yield

0.38%

Book Value (TTM)

₹  186.4877

CASH

154.65 Cr.

DEBT

55.99 Cr.

Promoter Holding

41.89%

EPS (TTM)

₹  75.4222

Sales Growth

12.4094391009476%

ROE

56.9301314172261 %

ROCE

68.0852893658584 %

Profit Growth

19.0707691333196 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year12.41%
3 Year38.66%
5 Year37.55%

Profit Growth (in Cr.)

1 Year52.64%
3 Year326.1%
5 Year49.31%

ROE%

1 Year56.93%
3 Year46.72%
5 Year24.39%

ROCE %

1 Year68.09%
3 Year46.21%
5 Year30.78%

Debt/Equity

0.0696

Price to Cash Flow

9.73

Interest Cover Ratio

26.4773053033923

CFO/PAT (5 Yr. Avg.)

4.83670732928704

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 41.89 0
Sep 2019 41.89 0
Jun 2019 41.89 0
Mar 2019 41.89 0
Dec 2018 41.19 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 326.101457932955% for the Past 3 years.
  • The company has shown a good revenue growth of 38.657246383636% for the Past 3 years.
  • The company has significantly decreased its debt by 228.01 Cr.
  • Company has been maintaining healthy ROE of 46.722670035693% over the past 3 years.
  • Company has been maintaining healthy ROCE of 46.2140565213713% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 26.4773053033923.
  • Company’s PEG ratio is 0.196640169501158.
  • The company has an efficient Cash Conversion Cycle of 39.9053455000595 days.
  • The company has a good cash flow management; CFO/PAT stands at 4.83670732928704.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 448.96 511.25 441.46 460.11 533.48
Total Expenditure 316.04 351.75 304.61 307.99 362.18
Operating Profit 132.92 159.5 136.85 152.12 171.3
Other Income 3.39 3.96 5.35 5.8 4.48
Interest 6.09 3.76 2.76 1.82 1.11
Depreciation 8.84 8.94 9.36 9.36 9.62
Exceptional Items 0 0 0 0 0
Profit Before Tax 121.38 150.76 130.08 146.74 165.05
Tax 33.68 52.75 39.82 19.2 38.09
Profit After Tax 87.7 98.01 90.26 127.54 126.96
Adjusted EPS (Rs) 1.54 1.72 1.59 2.17 2.16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 580.42 710.65 983.3 1685.33 1894.47
Total Expenditure 529.04 608.45 863.77 1275.68 1320.59
Operating Profit 51.37 102.2 119.53 409.65 573.88
Other Income 1.23 1.25 6.33 10.37 16.02
Interest 61.47 67.68 64.35 51.42 20.93
Depreciation 29.69 29.84 30.21 32.45 35.73
Exceptional Items 0 0 0 0 0
Profit Before Tax -38.55 5.93 31.3 336.15 533.24
Tax 1.48 1.26 3.6 99.45 171.95
Net Profit -40.03 4.67 27.7 236.7 361.29
Adjusted EPS (Rs.) -7.12 0.83 4.93 41.61 63.51

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 56.21 56.21 56.21 56.89 56.89
Total Reserves 128.92 132.49 159.53 417.45 756.65
Borrowings 301.88 284.98 258.12 189.88 0
Other N/C liabilities 2.55 9.25 22.17 20.77 79.73
Current liabilities 282.92 327.67 350.97 324.79 459.4
Total Liabilities 772.49 810.6 847 1009.78 1352.67
Assets
Net Block 399.5 373.88 405.64 411.72 469.04
Capital WIP 4.31 21.26 6.95 27.02 19.19
Investments 0.04 0.05 0 0 0
Loans & Advances 9.01 0.38 1.26 11.56 10.58
Other N/C Assets 2.77 0.37 2.17 7.3 5.81
Current Assets 356.86 414.66 430.98 552.18 848.05
Total Assets 772.49 810.6 847 1009.78 1352.67
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax -38.55 5.93 31.3 336.15 533.24
Adjustment 83.92 95.92 91.64 82.35 51.61
Working Capital Changes -27.67 -17.45 3.14 -77.64 3.39
Tax Paid 0 -1.06 -6.36 -67.69 -117.15
Operating Cash Flow 17.7 83.34 119.72 273.17 471.09
Investing Cash Flow -27.37 -22.78 -50.38 -63.04 -184.52
Financing Cash Flow 9.27 -59.78 -70.36 -197.46 -271.89
Net Cash Flow -0.4 0.78 -1.02 12.67 14.68

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

IOL Chem & Pharma Stock Price Analysis and Quick Research Report. Is IOL Chem & Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into IOL Chem & Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 471.09 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. IOL Chem & Pharma has a Debt to Equity ratio of 0.0696 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In IOL Chem & Pharma , the EPS growth was 52.6362484157161 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, IOL Chem & Pharma has OPM of 30.2923772875791 % which is a good sign for profitability.
     
  • ROE: IOL Chem & Pharma have a healthy ROE of 56.9301314172261 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about IOL Chem & Pharma

X